Factor VIII expression in azoxymethane-induced murine fulminant hepatic failure

Blood

Volumn 100, Issue 1, 2002, Pages 143-147

  Doering, Christopher B ^a   Josephson, Cassandra D ^a   Craddock, Heather N ^a   Lollar, Pete ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; MESSENGER RNA; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONCENTRATION RESPONSE; ENDOTHELIUM CELL; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; LIVER FAILURE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0036659924     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V100.1.143     Document Type: Article

References (46)

1. Bloom AL. The biosynthesis of factor VIII. Clin Haematol. 1979;8:53-77.
2. Graham JB, Collins DL, Brinkhous KM. Assay of plasma antihemophilic activity in normal, heterozygous (hemophilia) and prothrombinopenic dogs. Proc Soc Exp Biol Med. 1951;77:294-296.
3. Norman JC, Lambilliotte JP, Kojima Y, Sise HS. Antihemophilic factor release by per[used perfused liver and spleen: relationship to hemophilia. Science. 1967;58;1060-1061.
4. Lenting PJ, van Mourik JA, Mertens K. The life cycle of coagulation factor VIII in view of its structure and function. Blood. 1998;92:3983-3996.
5. Elder B, Lakich D, Gitschier J. Sequence of the murine factor VIII cDNA. Genomics. 1993;16:374-379.
6. Ringwald M, Eppig JT, Begley DA, et al. The mouse gene expression database. Nucleic Acids Res. 2001;29:98-101.
7. Wion KL, Kelly D, Summerfield JA, Tuddenham EG, Lawn RM. Distribution of factor VIII mRNA and antigen in human liver and other tissues. Nature. 1985;317:726-729.
8. Bontempo FA, Lewis JH, Gorenc TJ, et al. Liver transplantation in hemophilia A. Blood. 1987;69;1721-1724.
9. Scharrer I, Encke A, Hottenrott C. Clinical cure of haemophilia A by liver transplantation. Lancet. 1988;2:800-801.
10. Webster WP, Zukoski CF, Hutchin P, et al. Plasma factor VIII synthesis and control as revealed by canine organ transplantation. Am J Physiol. 1971;220:1147-1154.
11. Do H, Healey JF, Waller EK, Lollar P. Expression of factor VIII by murine liver sinusoidal endothelial cells. J Biol Chem. 1999;274:19587-19592.
12. Hellman L, Smedsrod B, Sandberg H, Pettersson U. Secretion of coagulant factor VIII activity and antigen by in vitro cultivated rat liver sinusoidal endothelial cells. Br J Haematol. 1989;73:348-355.
13. Stel HV, van der Kwast TH, Veerman EC. Detection of factor VIII/coagulant antigen in human liver tissue. Nature. 1983;303:530-532.
14. van der Kwast TH, Stel HV, Cristen E, Bertina RM, Veerman EC. Localization of factor VIII-procoagulant antigen: an immunohistological survey of the human body using monoclonal antibodies. Blood. 1986;67:222-227.
15. Zelechowska MG, van Mourik JA, Brodniewicz-Proba T. Ultrastructural localization of factor VIII procoagulant antigen in human liver hepatocytes. Nature, 1985;317;729-730.
16. Baele G, Vermeire P, Demeulenaere L, Barbier F. Elevation of factor VIII in acute liver necrosis. Influence of plasmapheresis. Digestion. 1973;8:360-367.
17. Langley PG, Hughes RD, Williams R. Increased factor VIII complex in fulminant hepatic failure. Thromb Haemost. 1985;54:693-696.
18. Meili EO, Straub PW. Elevation of factor VIII in acute fatal liver necrosis. Thromb Diath Haemorrh. 1970;24:161-174.
19. Pereira LM, Langley PG, Hayllar KM, Tredger JM, Williams R. Coagulation factor V and VIII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic failure: relation to other prognostic indicators. Gut. 1992:33:98-102.
20. Castelino DJ, Salem HH. Natural anticoagulants and the liver. J Gastroenterol Hepatol. 1997:12:77-83.
21. Langley PG, Williams R. The effect of fulminant hepatic failure on protein C antigen and activity. Thromb Haemost. 1988;59:316-318.
22. Matkowskyj KA, Marrero JA, Carroll RE, et al. Azoxymethane-induced fulminant hepatic failure in C57BL/6J mice: characterization of a new animal model. Am J Physiol. 1999;277:G455-G462.
23. Nichols WC, Cooney KA, Mohlke KL, et al. von Willebrand disease in the RIIIS/J mouse is caused by a defect outside of the von Willebrand factor gene. Blood. 1994;83:3225-3231.
24. Bonthron D, Orr EC, Mitsock LM, et al. Nucleotide sequence of pre-pro-von Willebrand factor cDNA. Nucleic Acids Res. 1986;14:7125-7127.
25. Hoyer LW, Wyshock EG, Salzman EW. Coagulation cofactors: factors V and VIII. In: Coleman RW, Hirsch J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis. Basic Principles and Clinical Practice. Philadelphia, PA: Lippincott; 1994:109-133.
26. Edmunds LH, Salzman EW. Hemostatic problems, transfusion therapy, and cardiopulmonary bypass in surgical patients. In: Coleman RW, Hirsch J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia, PA: Lippincott; 2001:956-968.
27. Powell EE, Kroon PA. Measurement of mRNA by quantitative PCR with a nonradioactive label, J Lipid Res. 1992;33:609-614.
28. Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA. The expression of TNF alpha by human muscle, Relationship to insulin resistance. J Clin Invest. 1996;97:1111-1116.
29. Wang AM, Doyle MV, Mark DF. Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci U S A. 1989;86:9717-9721.
30. Koene RA, Gerlag PG, Jansen JL, et al. Successful haemodialysis and renal transplantation in a patient with haemophilia A. Proc Eur Dial Transplant Assoc. 1977;14:401-406.
31. Marchioro TL, Hougie C, Ragde H, Epstein RB, Thomas ED. Hemophilia: role of organ homografts. Science. 1969;163:188-190.
32. Storb R, Marchioro TL, Graham TC, et al. Canine hemophilia and hemopoietic grafting. Blood. 1972;40:234-238.
33. Hathaway WE, Mull MM, Githens JH, et al. Attempted spleen transplant in classical hemophilia. Transplantation. 1969;7:73-75.
34. Norman JC, Covelli VH, Sise HS. Transplantation of the spleen: experimental cure of hemophilia. Surgery. 1968;64:1-14.
35. Norman JC, Covelli VH, Sise HS. Experimental transplantation of the spleen for classical hemophilia A. Rationales and long-term results. Bibl Haematol. 1970;34:187-199,
36. Liu DL, Xia S, Tang J, Qin X, Liu H. Allotransplantation of whole spleen in patients with hepatic malignant tumors or hemophilia A. Operative technique and preliminary results. Arch Surg. 1995;130:33-39.
37. Liu L, Xia S, Seifert J. Transplantation of spleen cells in patients with hemophilia A. A report of 20 cases. Transpl Int. 1994;7:201-206.
38. Maisonneuve P, Sultan Y. Modification of factor VIII complex properties in patients with liver disease. J Clin Pathol. 1977;30:221-227.
39. Fiore L, Levine J, Deykin D. Alterations in hemostasis in patients with liver disease. In: Zakim D, Boyer TD, eds. Hepatology. A Textbook of Liver Disease. Philadelphia, PA: Saunders; 1990:546-566.
40. Baele G, Matthijs E, Barbier F. Antihaemophilic factor A activity, F VIII-related antigen and von Willebrand factor in hepatic cirrhosis. Acta Haematol. 1977;57:290-297.
41. Green AJ, Ratnoff OD. Elevated antihemophilic factor (AHF, factor VIII) procoagulant activity and AHF-like antigen in alcoholic cirrhosis of the liver. J Lab Clin Med. 1974;83:189-197.
42. Kelly DA, O'Brien FJ, Hutton RA, et al. The effect of liver disease on factors V, VIII and protein C. Br J Haematol. 1985;61:541-548.
43. Meili EO, Frick PG, Straub PW. Coagulation changes during massive hepatic necrosis due to Amanita phalloides poisoning with special reference to antihemophilic globulin. Helv Med Acta. 1970;35:304-313.
44. Terblanche J, Hickman R. Animal models of fulminant hepatic failure. Dig Dis Sci. 1991;36:770-774.
45. Blitzer BL, Waggoner JG, Jones EA, et al. A model of fulminant hepatic failure in the rabbit. Gastroenterology. 1978;74:664-671.
46. Yamamoto K, de W, V, Fearns C, Loskutoff DJ. Tissue distribution and regulation of murine von Willebrand factor gene expression in vivo. Blood. 1998;92:2791-2801.